Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice

scientific article published on 20 June 2012

Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VIRUSRES.2012.06.014
P698PubMed publication ID22728446

P2093author name stringJimmy Kwang
Tanja K Kiener
Gijsbert M Grotenbreg
Annasaheb B Kolpe
P2860cites workEnterovirus 71 infection: a new threat to global public health?Q82263969
Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responsesQ82444268
Selection and characterization of vaccine strain for Enterovirus 71 vaccine developmentQ82811412
Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in miceQ82888730
Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infectionQ84059759
DNA vaccine constructs against enterovirus 71 elicit immune response in miceQ21245503
Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx moriQ30373913
Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.Q30384379
Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface.Q32060361
WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccineQ33396583
Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in miceQ33958090
Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infectionQ34141642
Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine productionQ34537049
Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse modelQ34742485
Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implicationsQ35124009
An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.Q35948053
The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoproteinQ36383213
Genetic evolution of enterovirus 71: epidemiological and pathological implicationsQ36815002
Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loadsQ37232853
Baculovirus as vaccine vectorsQ37731568
Virology, epidemiology, pathogenesis, and control of enterovirus 71.Q37801742
The effect of orientation within a chimeric peptide on the immunogenicity of Chlamydia trachomatis epitopesQ37885456
The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequencesQ39340684
Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodonQ39825058
The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains.Q39827005
Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite proteinQ40197184
Immunogenicity of formaldehyde and binary ethylenimine inactivated infectious bursal disease virus in broiler chicksQ41854986
Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against diseaseQ41988715
Properties of baculovirus particles displaying GFP analyzed by fluorescence correlation spectroscopyQ42049124
Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine modelsQ43001874
Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.Q44566080
Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccineQ45145708
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvantQ45391143
Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challengeQ45396589
Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in miceQ45722509
Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virusQ45734536
Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007.Q46550828
Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeysQ46801574
Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C virusesQ48065338
Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edemaQ48235723
Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptidesQ79557916
Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005Q80290931
P433issue1-2
P304page(s)64-72
P577publication date2012-06-20
P1433published inVirus ResearchQ15749215
P1476titleDisplay of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice
P478volume168

Reverse relations

cites work (P2860)
Q40925262A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice
Q33685512A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein
Q56514706Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
Q40880160Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection
Q27010349Is a multivalent hand, foot, and mouth disease vaccine feasible?
Q34580095Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice

Search more.